| Literature DB >> 28886009 |
Q-Z Tuo1,2,3, P Lei2,3, K A Jackman2, X-L Li2,4, H Xiong3, X-L Li2,4, Z-Y Liuyang1, L Roisman5, S-T Zhang3, S Ayton2, Q Wang3, P J Crouch5, K Ganio2, X-C Wang1, L Pei6, P A Adlard2, Y-M Lu1, R Cappai5, J-Z Wang1, R Liu1, A I Bush2.
Abstract
Functional failure of tau contributes to age-dependent, iron-mediated neurotoxicity, and as iron accumulates in ischemic stroke tissue, we hypothesized that tau failure may exaggerate ischemia-reperfusion-related toxicity. Indeed, unilateral, transient middle cerebral artery occlusion (MCAO) suppressed hemispheric tau and increased iron levels in young (3-month-old) mice and rats. Wild-type mice were protected by iron-targeted interventions: ceruloplasmin and amyloid precursor protein ectodomain, as well as ferroptosis inhibitors. At this age, tau-knockout mice did not express elevated brain iron and were protected against hemispheric reperfusion injury following MCAO, indicating that tau suppression may prevent ferroptosis. However, the accelerated age-dependent brain iron accumulation that occurs in tau-knockout mice at 12 months of age negated the protective benefit of tau suppression against MCAO-induced focal cerebral ischemia-reperfusion injury. The protective benefit of tau knockout was revived in older mice by iron-targeting interventions. These findings introduce tau-iron interaction as a pleiotropic modulator of ferroptosis and ischemic stroke outcome.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28886009 DOI: 10.1038/mp.2017.171
Source DB: PubMed Journal: Mol Psychiatry ISSN: 1359-4184 Impact factor: 15.992